Ashkon Software

   







 


ABT Stock Report - Abbott Laboratories

Abbott Laboratories logoAbbott Laboratories is a global healthcare company that focuses on discovering, developing, manufacturing, and selling healthcare products worldwide. The company operates in four main segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices.

The Established Pharmaceutical Products segment is responsible for producing generic pharmaceuticals used for treating a wide range of conditions. Thesse include pancreatic exocrine insufficiency, hypertension, pain relief, hormone replacement therapy, and dyslipidemia, as well as providing anti-infective and influenza vaccines.

The Diagnostic Products segment provides laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion. It also offers point of care systems, rapid diagnostics, and molecular point-of-care testing for various illnesses such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A.

The Nutritional Products segment specializes in providing pediatric and adult nutritional products. The Medical Devices segment focuses on offering a range of devices for the treatment of cardiovascular diseases, including rhythm management, electrophysiology, heart failure, vascular, and structural heart devices. Additionally, it provides diabetes care products and neuromodulation devices for managing chronic pain and movement disorders.

Founded in 1888, Abbott Laboratories is headquartered in North Chicago, Illinois. The company has a long-standing history in the healthcare industry and continues to make strides in developing innovative products and solutions to meet the changing needs of patients around the world.

 



Stock Sector: Drugs: Manufacturers - Major


 

 
Copyright © 2000-2024, Ashkon Software LLC
Privacy Policy | Refund Policy | Disclaimer